Valganciclovir hydrochloride is an antiviral medication classified as the L-valyl ester prodrug of ganciclovir, commonly prescribed to treat cytomegalovirus (CMV) infections in immunocompromised patients.… Read more
Valganciclovir hydrochloride is an antiviral medication classified as the L-valyl ester prodrug of ganciclovir, commonly prescribed to treat cytomegalovirus (CMV) infections in immunocompromised patients. By enhancing oral bioavailability before conversion into the active nucleoside analogue, this prodrug requires precise analytical monitoring to ensure therapeutic efficacy and safety. Laboratories utilize our comprehensive range of high-quality reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, to facilitate rigorous impurity profiling and method validation. These critical analytical tools allow researchers and quality control professionals to accurately detect and quantify impurities, support stability studies, and ensure compliance with regulatory standards throughout the pharmaceutical development and manufacturing lifecycle.